| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $2.00 | $0.54 | $0.49 | $0.72 | $0.46 | $0.86 | $0.62 | $0.59 |
| EPS (Diluted) | $1.99 | $0.54 | $0.49 | $0.72 | $0.46 | $0.86 | $0.62 | $0.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.0B | $27.9B | $27.7B | $26.6B | $25.9B | $18.5B | $13.7B | $12.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.2B |
| Total Liabilities | $27.8B | $24.7B | $24.7B | $23.8B | $22.8B | $16.2B | $11.7B | $10.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.2B | $3.2B | $3.0B | $2.8B | $3.2B | $2.3B | $2.0B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.5B | $0.5B | $0.6B | $0.2B | $0.2B | $0.3B |
| Investing Cash Flow | $1.1B | $0.5B | $-0.2B | $-1.4B | $-3.9B | $-3.6B | $-0.0B | $-0.9B |
| Capital Expenditures | $0.0B | $0.0B | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-1.3B | $0.7B | $0.8B | $3.1B | $3.7B | $-0.1B | $0.6B |